scholarly journals Future directions in bladder cancer immunotherapy: towards adaptive immunity

Immunotherapy ◽  
2016 ◽  
Vol 8 (3) ◽  
pp. 351-365 ◽  
Author(s):  
Sean G Smith ◽  
David A Zaharoff
Keyword(s):  
Bladder Cancer ◽  
Cancer Immunotherapy ◽  
Adaptive Immunity ◽  
Future Directions

Current Status and Future Directions of Nanoparticulate Strategy for Cancer Immunotherapy

2016 ◽  
Vol 17 (8) ◽  
pp. 755-762 ◽  
Author(s):  
Xu Zhou ◽  
Renhe Liu ◽  
Shuo Qin ◽  
Ruilian Yu ◽  
Yao Fu
Keyword(s):  
Cancer Immunotherapy ◽  
Current Status ◽  
Future Directions

scholarly journals Complete Response With Immunotherapy: A Case of Metastatic Bladder Cancer

2021 ◽  
Vol 9 ◽  
pp. 232470962110356
Author(s):  
Balraj Singh ◽  
Parminder Kaur ◽  
Sachin Gupta ◽  
Nirmal Guragai ◽  
Michael Maroules
Keyword(s):  
Bladder Cancer ◽  
Cancer Immunotherapy ◽  
Locally Advanced ◽  
Complete Response ◽  
First Line ◽  
Novel Therapy ◽  
Metastatic Bladder Cancer ◽  
Metastatic Urothelial Cancer ◽  
Platinum Based Chemotherapy ◽  
Broad Variety

Bladder cancer is the most common urinary tract malignancy. Platinum-based chemotherapy is the first line of treatment in locally advanced or metastatic bladder cancer. Immunotherapy has become a novel therapy option in a broad variety of malignancies including bladder cancer. Immunotherapy is approved as first line of treatment in patients who are ineligible for platinum-based chemotherapy and second-line treatment for metastatic urothelial cancer who progressed after platinum-based treatments. We present the case of an 83-year-old female with metastatic bladder cancer who was chemotherapy ineligible and had complete response with immune checkpoint inhibitor pembrolizumab.

PMN and anti-tumor immunity—The case of bladder cancer immunotherapy

2013 ◽  
Vol 23 (3) ◽  
pp. 183-189 ◽  
Author(s):  
Erik L. Brincks ◽  
Michael C. Risk ◽  
Thomas S. Griffith
Keyword(s):  
Bladder Cancer ◽  
Cancer Immunotherapy ◽  
Tumor Immunity

Coupling Innate and Adaptive Immunity with Yeast-Based Cancer Immunotherapy

2007 ◽  
pp. 131-149 ◽  
Author(s):  
Sibyl Munson ◽  
Joanne Parker ◽  
Thomas H. King ◽  
Yingnian Lu ◽  
Victoria Kelley ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Adaptive Immunity ◽  
Innate And Adaptive Immunity

scholarly journals Activation of innate and adaptive immunity as an effective combined strategy for cancer immunotherapy

2015 ◽  
Vol 3 (S2) ◽  
Author(s):  
Alexander Rakhmilevich ◽  
Mildred Felder ◽  
Lauren Lever ◽  
Tyler Van De Voort ◽  
Alan J Korman ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Adaptive Immunity ◽  
Innate And Adaptive Immunity ◽  
Combined Strategy

Bladder Cancer Immunotherapy

1982 ◽  
Vol 128 (5) ◽  
pp. 931-935 ◽  
Author(s):  
Donald L. Lamm ◽  
Daniel E. Thor ◽  
Valerie D. Stogdill ◽  
Howard M. Radwin
Keyword(s):  
Bladder Cancer ◽  
Cancer Immunotherapy

scholarly journals Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions

2020 ◽  
Vol 6 (1) ◽  
pp. 9-23
Author(s):  
Kyle B. Zuniga ◽  
Rebecca E. Graff ◽  
David B. Feiger ◽  
Maxwell V. Meng ◽  
Sima P. Porten ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Recurrence ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Future Directions ◽  
Muscle Invasive ◽  
Bladder Cancer Recurrence

Bladder Cancer: Management and Future Directions

2007 ◽  
Vol 6 (3) ◽  
pp. 365-373 ◽  
Author(s):  
Christopher P. Evans ◽  
Frans M.J. Debruyne ◽  
Heather Payne ◽  
Eduardo Solsona ◽  
Pierre Teillac ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Future Directions ◽  
Cancer Management
Sign in / Sign up

Export Citation Format

Share Document